United States · FDA National Drug Code directory
Irinotecan Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-401_b3cfa0f6-fbdc-4f19-9dac-beaf398603d8
- Product NDC
- 50742-401
- Form
- INJECTION
- Composition / generic term
- Irinotecan Hydrochloride
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170605 / 20260930
Source-listed ingredients
- IRINOTECAN HYDROCHLORIDE — 40 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (50742-401-02) / 2 mL in 1 VIAL, GLASS · 50742-401-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →